Lundbeck Executive and Leadership Team

Erol Özata, the Manager, Finance & Operations & Chief Financial Officer at Lundbeck, directs the company's financial strategy and operational efficiency. Özata oversees all financial planning, budgeting, and reporting, ensuring fiscal responsibility and driving profitable growth in the competitive pharmaceutical market. The Chief Financial Officer's responsibilities extend to managing operational workflows, optimizing resource allocation, and identifying cost-saving opportunities to enhance Lundbeck's overall performance. Erol Özata's leadership ensures that financial resources are strategically deployed to support the research and development of treatments for psychiatric and neurological disorders. This involves close collaboration with research teams and market access departments to align financial objectives with scientific advancements and commercial goals. Özata's financial acumen is crucial for sustaining Lundbeck's long-term viability and expanding its global reach.

Jovanni Figaro Oliver, the President at Lundbeck, drives the company's overarching strategic direction and market positioning. Oliver leads initiatives focused on expanding Lundbeck's portfolio of treatments for psychiatric and neurological disorders, ensuring alignment with global healthcare needs. The President's role involves fostering innovation, cultivating key partnerships, and overseeing the execution of strategic plans across various business units. Jovanni Figaro Oliver's leadership guides the company's efforts to enhance patient access to critical therapies and strengthen its presence in key international markets. This includes directing market development strategies and ensuring operational excellence throughout the organization. Oliver's vision is instrumental in advancing Lundbeck's mission to improve the lives of individuals affected by brain diseases, solidifying the company's leadership in neuroscience.

Joanna Alvarez, the President at Lundbeck, spearheads critical strategic growth initiatives and operational oversight. Alvarez focuses on advancing Lundbeck's commitment to developing innovative treatments for psychiatric and neurological disorders, ensuring robust pipeline development and market penetration. The President's responsibilities encompass driving cross-functional collaboration, optimizing global operations, and enhancing stakeholder engagement to support the company's mission. Joanna Alvarez's leadership is vital in navigating the complex pharmaceutical landscape, fostering a culture of scientific excellence, and ensuring the effective delivery of therapies to patients worldwide. This involves directing efforts to expand market reach and solidify Lundbeck's reputation as a leader in brain health. Alvarez's strategic guidance is essential for achieving long-term success and improving patient outcomes.

Marilyn Singer, the Corporate Executive Administrator at Lundbeck, manages critical administrative functions supporting executive operations. Singer ensures seamless coordination across departments, facilitating efficient communication and workflow for senior leadership. This role involves overseeing executive scheduling, travel arrangements, and the preparation of essential documentation, all vital for the smooth functioning of the company's strategic initiatives. Marilyn Singer's oversight guarantees that administrative processes align with Lundbeck's mission to develop treatments for psychiatric and neurological disorders. The administrator's diligence directly supports the executive team's ability to focus on research, development, and market expansion within the pharmaceutical sector. Singer's contribution is foundational to maintaining operational excellence and supporting Lundbeck's global presence in healthcare.